Singmed opens Asia's largest inhaler production base in Changshu, China

Singmed Medical Device Science and Technology opened a CNY500 million (USD70 million) inhaler production base in Changshu, Jiangsu province, with an annual capacity of 50 million nebulizers.

“Inhalers are one of the keys to the development of homegrown inhaled medication.”yicaiglobal.com

• 1 source
• yicaiglobal.comChina’s Singmed Opens Asia’s Biggest Inhaler Production BaseLin ZhiyinAug 7, 2024

Summarized from public sources; check the original articles before acting on it.